Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Suspended × Trastuzumab × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Completed 186 Unknown 57 Terminated 48 Recruiting 43 Active not recruiting 31 Not yet recruiting 14 Withdrawn 11 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 1

Interventions

Specimen Handling 7 Magnetic Resonance Spectroscopy 7 Biopsy 6 pembrolizumab 4 Capecitabine 4 Radiosurgery 3 Nivolumab 3 Fluorouracil 3 Docetaxel 3 Bevacizumab 3 trifluridine tipiracil drug combination 2 spartalizumab 2 lenvatinib 2 balstilimab 2 atezolizumab 2 Radiation 2 Paclitaxel 2 Oxaliplatin 2 Mitoxantrone 2 Leucovorin 2 Lenalidomide 2 Irinotecan 2 Gemcitabine 2 Epirubicin 2 Drug Therapy 2 Cyclophosphamide 2 Cisplatin 2 zanubrutinib 1 venetoclax 1 tucatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05062889 2026-02-03

ERASE-CRC

Gruppo Oncologico del Nord-Ovest

Phase 2 Suspended

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡